210 related articles for article (PubMed ID: 17166107)
1. The obesity syndrome and acanthosis nigricans. Acanthosis nigricans is a common cosmetic problem providing epidemiological clues to the obesity syndrome, the insulin-resistance syndrome, the thrifty metabolism, dyslipidaemia, hypertension and diabetes mellitus type II.
Maitra SK; Rowland Payne CM
J Cosmet Dermatol; 2004 Dec; 3(4):202-10. PubMed ID: 17166107
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance (metabolic) syndrome in children.
Rosenberg B; Moran A; Sinaiko AR
Panminerva Med; 2005 Dec; 47(4):229-44. PubMed ID: 16489322
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of acanthosis nigricans and its correlates in a cross-section of Nigerians with type 2 diabetes mellitus.
Ogbera AO; Akinlade A; Ajose O; Awobusuyi J
Trop Doct; 2009 Oct; 39(4):235-6. PubMed ID: 19762579
[TBL] [Abstract][Full Text] [Related]
4. The deadly quartet--the insulin resistance syndrome.
Opara JU; Levine JH
South Med J; 1997 Dec; 90(12):1162-8. PubMed ID: 9404899
[TBL] [Abstract][Full Text] [Related]
5. Acanthosis nigricans in obese patients: Presentations and implications for prevention of atherosclerotic vascular disease.
Katz AS; Goff DC; Feldman SR
Dermatol Online J; 2000 Sep; 6(1):1. PubMed ID: 11328611
[TBL] [Abstract][Full Text] [Related]
6. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
Chapman MJ; Sposito AC
Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
[TBL] [Abstract][Full Text] [Related]
7. IAP National Task Force for Childhood Prevention of Adult Diseases: insulin resistance and Type 2 diabetes mellitus in childhood.
Bhatia V;
Indian Pediatr; 2004 May; 41(5):443-57. PubMed ID: 15181295
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
da Silva RC; Miranda WL; Chacra AR; Dib SA
J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
[TBL] [Abstract][Full Text] [Related]
9. Juvenile acanthosis nigricans.
Sinha S; Schwartz RA
J Am Acad Dermatol; 2007 Sep; 57(3):502-8. PubMed ID: 17592743
[TBL] [Abstract][Full Text] [Related]
10. Syndrome X. Recognition and management of this metabolic disorder in primary care.
Minchoff LE; Grandin JA
Nurse Pract; 1996 Jun; 21(6):74-5, 79-80, 83-6. PubMed ID: 8784876
[TBL] [Abstract][Full Text] [Related]
11. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
12. [From obesity to type 2 diabetes in children and adolescents].
Theintz G
Rev Med Suisse; 2005 Feb; 1(7):477-80. PubMed ID: 15790014
[TBL] [Abstract][Full Text] [Related]
13. HAIR-AN syndrome: a multisystem challenge.
Elmer KB; George RM
Am Fam Physician; 2001 Jun; 63(12):2385-90. PubMed ID: 11430453
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of childhood type 2 diabetes in the developing world.
Singh R; Shaw J; Zimmet P
Pediatr Diabetes; 2004 Sep; 5(3):154-68. PubMed ID: 15450011
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome and the menopause.
Kaaja RJ
Menopause Int; 2008 Mar; 14(1):21-5. PubMed ID: 18380957
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of insulin resistance in obese women with and without acanthosis nigricans.
Sadeghian G; Ziaie H; Amini M; Ali Nilfroushzadeh M
J Dermatol; 2009 Apr; 36(4):209-12. PubMed ID: 19348659
[TBL] [Abstract][Full Text] [Related]
17. [From type 2 diabetes to metabolic X syndrome].
Pogátsa G
Orv Hetil; 1999 Mar; 140(12):635-40. PubMed ID: 10217954
[TBL] [Abstract][Full Text] [Related]
18. Significance of acanthosis nigricans in childhood obesity.
Guran T; Turan S; Akcay T; Bereket A
J Paediatr Child Health; 2008 Jun; 44(6):338-41. PubMed ID: 18476925
[TBL] [Abstract][Full Text] [Related]
19. [Leptin and its association with obesity and type 2 diabetes].
Almanza-Pérez JC; Blancas-Flores G; García-Macedo R; Alarcón-Aguilar FJ; Cruz M
Gac Med Mex; 2008; 144(6):535-42. PubMed ID: 19112726
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic medications: metabolic and cardiovascular risk.
Newcomer JW
J Clin Psychiatry; 2007; 68 Suppl 4():8-13. PubMed ID: 17539694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
